Abstract
SUMMARY Using the effect of insulin on isolated rat hemidiaphragm as an assay system, it has been possible to demonstrate a circulating insulin antagonist in some new cases of diabetes of the growth-onset type as well as during the exacerbation of diabetes secondary to infections. Three out of four acromegalics with diabetes also showed evidence of insulin antagonist, while one diabetic patient with thyrotoxicosis requiring 155 u. insulin/day had no antagonist. The antagonist present in the new diabetics and during infection exhibited some characteristics similar to the antagonist previously described during diabetic acidosis [Field & Stetten, 1956a], but different from the insulin inhibitor present during chronic insulin resistance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
